@article{oai:niigata-u.repo.nii.ac.jp:00016192,
 author = {相田, 浩},
 issue = {2},
 journal = {新潟医学会雑誌, 新潟医学会雑誌},
 month = {Feb},
 note = {Approximately 5－10％ of breast and ovarian cancer cases are due to an inherited susceptibility. The majority of inherited and ovarian cancers. unceptibillity is due to reputations in the BRCA 1 and BRCA 2 genes, however, other genes responsible for inherited susceptibility to these diseases are yet to be identified. Genetic testing for inherited cancer susceptibility will play an increasingly important role in health care. Providing accurate cancer, risk assessment and identifying appropriate individuals for genetic testing for cancer susceptibility mutations can lead to improve strategies for screening and prevention methods. Genetic testing for inherited cancer susceptibility can affect an individual’s personal, medical, psychological, familial, social, ethical and financial well－being, however, the benefits and longterm effects of this testing are not yet clear. It is therefore prudent for all health care professionals to follow published guidelines and recommendations for providing testing for inherited cancer susceptibility to ensure informed consent and minimize harm to individuals and their families},
 pages = {94--98},
 title = {4）産婦人科疾患における遺伝子診断（シンポジウム 遺伝子診断の最近の進歩, 第541回新潟医学会 ）},
 volume = {113},
 year = {1999}
}